Mumbai-based startup Patanjali Pharma has developed a Rapid Antigen Test that offers Covid-19 diagnosis and surveillance at the cost of ₹100 per test. The test will complement the gold standard RT PCR and Rapid antigen tests and make it one of the most affordable ones available in the market.
The IIT-Bombay incubatee has validated the product at different Covid-19 centres and has applied for a licence.
Dr. Vinay Saini, Director, Patanjali Pharma, said the company plans to launch the rapid Covid-19 antigen tests in early June 2021. The Rapid covid-19 tests (~10-15 minutes) would be helpful for early diagnosis of Covid-19 in rural areas, doctors’ clinics, and resource constraint areas where pathology and diagnostic labs are not available, Saini said in a press release.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.